Clinical Trial Update: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection [Phase 3]

View source ↗

Summary

This document updates on a Phase 3 clinical trial (NCT06829784) evaluating an injectable treatment, TQC2731, for severe asthma, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TQC2731

Snippet

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Conditions: Asthma | Phase 3 | Status: RECRUITING